Abstract

The contractor will conduct a pre-surgical 2-arm pilot study to evaluate the effect of 3-4 monthly doses of denosumab on proliferation of fallopian tube epithelial cells in pre-menopausal women carrying a BRCA1/2 mutation.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
261201200034I-0-26100013-1
Application #
9575770
Study Section
Project Start
2017-09-21
Project End
2019-09-20
Budget Start
Budget End
Support Year
Fiscal Year
2017
Total Cost
Indirect Cost

  Institution

Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030